tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Bayer’s BAY2862789: A Promising Step in Cancer Treatment
Company AnnouncementsBayer’s BAY2862789: A Promising Step in Cancer Treatment
8h ago
Bayer’s FINE-REAL Study: Real-World Insights on Finerenone Use in CKD and T2D
PremiumCompany Announcements
Bayer’s FINE-REAL Study: Real-World Insights on Finerenone Use in CKD and T2D
1d ago
Bayer’s Innovative Approach in Prostate Cancer Treatment: A Closer Look at the 225Ac-PSMA-Trillium Study
PremiumCompany Announcements
Bayer’s Innovative Approach in Prostate Cancer Treatment: A Closer Look at the 225Ac-PSMA-Trillium Study
1d ago
AstraZeneca and Bayer’s Collaborative Study on Metastatic Prostate Cancer: A Potential Game-Changer?
PremiumCompany Announcements
AstraZeneca and Bayer’s Collaborative Study on Metastatic Prostate Cancer: A Potential Game-Changer?
1d ago
AZN
Bayer’s Darolutamide Study: Real-World Insights into Prostate Cancer Treatment
PremiumCompany Announcements
Bayer’s Darolutamide Study: Real-World Insights into Prostate Cancer Treatment
1d ago
Bayer’s Vericiguat Study: Real-World Insights into Heart Failure Treatment
PremiumCompany AnnouncementsBayer’s Vericiguat Study: Real-World Insights into Heart Failure Treatment
1d ago
Avidity, Phathom mentioned as potential takeout targets at Needham
Premium
The Fly
Avidity, Phathom mentioned as potential takeout targets at Needham
1d ago
BMY
NVO
Bayer’s emodepside granted FDA orphan designation
Premium
The Fly
Bayer’s emodepside granted FDA orphan designation
2d ago
Bayer AG’s Observational Study on Vericiguat: A Real-World Insight into Heart Failure Treatment
PremiumCompany Announcements
Bayer AG’s Observational Study on Vericiguat: A Real-World Insight into Heart Failure Treatment
2d ago
Bayer’s New Study on Mirena: A Game Changer for Women’s Health?
PremiumCompany Announcements
Bayer’s New Study on Mirena: A Game Changer for Women’s Health?
2d ago
Bayer AG Management Engages in Share Purchase to Boost Stakeholder Confidence
PremiumCompany Announcements
Bayer AG Management Engages in Share Purchase to Boost Stakeholder Confidence
2d ago
Bayer’s Pioneering Study on 225Ac-PSMA-Trillium for Advanced Prostate Cancer: A Potential Game Changer?
PremiumCompany Announcements
Bayer’s Pioneering Study on 225Ac-PSMA-Trillium for Advanced Prostate Cancer: A Potential Game Changer?
3d ago
Bayer’s Darolutamide Study: Real-World Insights into Prostate Cancer Treatment
PremiumCompany AnnouncementsBayer’s Darolutamide Study: Real-World Insights into Prostate Cancer Treatment
3d ago
Bayer’s FINE-REAL Study: Real-World Insights into Finerenone Use
Premium
Company Announcements
Bayer’s FINE-REAL Study: Real-World Insights into Finerenone Use
3d ago
AstraZeneca and Bayer’s Promising Prostate Cancer Study: Key Insights for Investors
Premium
Company Announcements
AstraZeneca and Bayer’s Promising Prostate Cancer Study: Key Insights for Investors
3d ago
AZN
Bayer’s Observational Study Explores Sepsis, VTE, and DIC Relationships
PremiumCompany Announcements
Bayer’s Observational Study Explores Sepsis, VTE, and DIC Relationships
4d ago
Bayer Completes Study on Finerenone for CKD and T2D in India: Market Implications
PremiumCompany Announcements
Bayer Completes Study on Finerenone for CKD and T2D in India: Market Implications
7d ago
Bayer’s Observational Study on DIC in Japan: A Potential Game Changer
PremiumCompany Announcements
Bayer’s Observational Study on DIC in Japan: A Potential Game Changer
7d ago
Bayer’s Xofigo Study Update: Implications for Prostate Cancer Treatment and Market Impact
PremiumCompany Announcements
Bayer’s Xofigo Study Update: Implications for Prostate Cancer Treatment and Market Impact
8d ago
Bayer AG’s VITRAKVI Study: A Potential Game-Changer in TRK Fusion Cancer Treatment
PremiumCompany AnnouncementsBayer AG’s VITRAKVI Study: A Potential Game-Changer in TRK Fusion Cancer Treatment
8d ago
Bayer’s Observational Study on Eylea in Preterm Infants: Market Implications
Premium
Company Announcements
Bayer’s Observational Study on Eylea in Preterm Infants: Market Implications
9d ago
Bayer’s Finerenone Study in India: A Boost for CKD Treatment Market
Premium
Company Announcements
Bayer’s Finerenone Study in India: A Boost for CKD Treatment Market
9d ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >